Solid Tumor, Adult Clinical Trials in San Antonio, Texas

9 recruitingSan Antonio, Texas

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Solid Tumor, Adult
BioInvent International AB197 enrolled25 locationsNCT04219254
Recruiting
Phase 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Metastatic Breast CancerAdvanced Breast CancerMetastatic Lung Cancer+6 more
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 enrolled36 locationsNCT06625775
Recruiting
Phase 1Phase 2

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

NSCLCSolid Tumor, AdultMesothelioma
Vivace Therapeutics, Inc434 enrolled12 locationsNCT04665206
Recruiting
Phase 1

First In Human Study of CX-2051 in Advanced Solid Tumors

Solid Tumor, Adult
CytomX Therapeutics160 enrolled5 locationsNCT06265688
Recruiting
Phase 1

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

CancerSolid Tumor, Adult
Shenzhen Ionova Life Sciences Co., Ltd.78 enrolled3 locationsNCT04443088
Recruiting
Phase 1Phase 2

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Metastatic Solid TumorSolid Tumor, AdultUnresectable Solid Tumor+1 more
Frontier Medicines Corporation403 enrolled26 locationsNCT06244771
Recruiting
Phase 1

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Solid Tumor, Adult
Kumquat Biosciences Inc.100 enrolled35 locationsNCT06507306
Recruiting
Phase 1Phase 2

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

Solid Tumor, Adult
Linnaeus Therapeutics, Inc.200 enrolled10 locationsNCT04130516
Recruiting
Phase 1Phase 2

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

Solid Tumor, Adult
Effector Therapeutics30 enrolled14 locationsNCT04092673